Khojasteh-Bakht SC[au] - Search Results

Year	Number of Results
1996	1
1998	1
1999	2
2002	1
2003	1
2004	1
2005	2
2007	2
2009	1
2010	1
2022	0

1

Biotransformation reactions of five-membered aromatic heterocyclic rings.

Dalvie DK, Kalgutkar AS, Khojasteh-Bakht SC, Obach RS, O'Donnell JP. Dalvie DK, et al. Among authors: khojasteh bakht sc. Chem Res Toxicol. 2002 Mar;15(3):269-99. doi: 10.1021/tx015574b. Chem Res Toxicol. 2002. PMID: 11896674 Review. No abstract available.

2

Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature.

Anderson IB, Mullen WH, Meeker JE, Khojasteh-BakhtSC, Oishi S, Nelson SD, Blanc PD. Anderson IB, et al. Ann Intern Med. 1996 Apr 15;124(8):726-34. doi: 10.7326/0003-4819-124-8-199604150-00004. Ann Intern Med. 1996. PMID: 8633832 Review.

3

Inhibitory properties of trapping agents: glutathione, potassium cyanide, and methoxylamine, against major human cytochrome p450 isoforms.

Zhang C, Wong S, Delarosa EM, Kenny JR, Halladay JS, Hop CE, Khojasteh-Bakht SC. Zhang C, et al. Among authors: khojasteh bakht sc. Drug Metab Lett. 2009 Apr;3(2):125-9. doi: 10.2174/187231209788654126. Drug Metab Lett. 2009. PMID: 19601875

4

Metabolic stability screen for drug discovery using cassette analysis and column switching.

Halladay JS, Wong S, Jaffer SM, Sinhababu AK, Khojasteh-Bakht SC. Halladay JS, et al. Among authors: khojasteh bakht sc. Drug Metab Lett. 2007 Jan;1(1):67-72. doi: 10.2174/187231207779814364. Drug Metab Lett. 2007. PMID: 19356021

5

Metabolism, pharmacokinetics, tissue distribution, and excretion of [14C]CP-424391 in rats.

Khojasteh-Bakht SC, O'donnell JP, Fouda HG, Potchoiba MJ. Khojasteh-Bakht SC, et al. Drug Metab Dispos. 2005 Jan;33(1):190-9. doi: 10.1124/dmd.104.001065. Epub 2004 Oct 14. Drug Metab Dispos. 2005. PMID: 15486077

6

Glutathione S-transferase catalyzes the isomerization of (R)-2-hydroxymenthofuran to mintlactones.

Khojasteh-Bakht SC, Nelson SD, Atkins WM. Khojasteh-Bakht SC, et al. Arch Biochem Biophys. 1999 Oct 1;370(1):59-65. doi: 10.1006/abbi.1999.1361. Arch Biochem Biophys. 1999. PMID: 10496977

7

(R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.

Khojasteh-Bakht SC, Koenigs LL, Peter RM, Trager WF, Nelson SD. Khojasteh-Bakht SC, et al. Drug Metab Dispos. 1998 Jul;26(7):701-4. Drug Metab Dispos. 1998. PMID: 9660853

8

Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.

Prakash C, O'Donnell J, Khojasteh-Bakht SC. Prakash C, et al. Among authors: khojasteh bakht sc. Drug Metab Dispos. 2007 Jul;35(7):1071-80. doi: 10.1124/dmd.107.015362. Epub 2007 Apr 12. Drug Metab Dispos. 2007. PMID: 17431029 Clinical Trial.

9

Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543.

Khojasteh-Bakht SC, Rossulek MI, Fouda HG, Prakash C. Khojasteh-Bakht SC, et al. Xenobiotica. 2003 Dec;33(12):1201-10. doi: 10.1080/00498250310001646362. Xenobiotica. 2003. PMID: 14742142

10

Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.

Khojasteh-Bakht SC, Chen W, Koenigs LL, Peter RM, Nelson SD. Khojasteh-Bakht SC, et al. Drug Metab Dispos. 1999 May;27(5):574-80. Drug Metab Dispos. 1999. PMID: 10220485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results